A detailed look at MilliporeSigma’s new BioReliance® viral vector manufacturing facility and how we have employed the latest innovations and quality systems to deliver best-in-class gene therapy services.
Not yet a member of Cell & Gene? Register today.
Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.
You might also want to: